Cytochrome p450 enzymes and cardiovascular disease

Author： Hunter Arwen L   Cruz Rani P   Cheyne Bo M   McManus Bruce M   Granville David J  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.82, Iss.12, 2004-12, pp. : 1053-1060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 in Neurological Disease

By  

Current Drug Metabolism, Vol. 5, Iss. 3, 2004-06 ,pp. : 225-234

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Effects of icaritin on cytochrome P450 enzymes in rats

By Liang Dong-Lou   Zheng Shuang-Li  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 4, 2014-04 ,pp. : 301-305

Govi-Verlag

Access to resources Recommend Favorite

The role of pharmacogenetically-variable cytochrome P450 enzymes in

By Howard Lisa A   Sellers Edward M   Tyndale Rachel F  

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 185-199

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Cytochrome P450 Enzymes in Tumours

By  

Current Pharmacogenomics, Vol. 2, Iss. 3, 2004-09 ,pp. : 243-254

Bentham Science Publishers

Access to resources Recommend Favorite